29.07.2025 16:18

180 Life Sciences Corp. (ATNF), a biotechnology company, is undergoing a dramatic transformation, pivoting its focus towards Ethereum and rebranding itself as ETHZilla. This significant shift is fueled by a substantial $425 million private investment in public equity (PIPE) deal. The infusion of capital will allow the company to significantly bolster its Ethereum treasury.


This bold strategic move has sent ripples through the financial markets, resulting in a notable surge in ATNF's stock price. The company's new Ethereum-centric strategy, coupled with its eye-catching rebrand, has garnered considerable attention from investors and industry analysts alike.


The $425 million PIPE deal is the cornerstone of this ambitious project. Not only does it provide the financial backing for ETHZilla's operations, but it also demonstrates a strong belief in Ethereum's long-term potential. This investment underscores the growing intersection between traditional finance and decentralized technologies.


Beyond the financial commitment, ETHZilla plans to actively participate in the broader Ethereum ecosystem. This includes involvement with the DeFi Council and a leadership role in shaping the future of Ethereum finance. The rebranding itself signifies a complete departure from the company's previous focus, representing a decisive commitment to the Ethereum blockchain.


In summary, 180 Life Sciences' transformation into ETHZilla, powered by a massive $425 million investment, marks a significant development in the intersection of traditional finance and the decentralized finance (DeFi) world. This bold strategy, coupled with a compelling rebrand, positions the company for a future deeply integrated within the Ethereum ecosystem. The considerable stock price increase reflects investor enthusiasm for this high-stakes gamble on the future of Ethereum. The information from internet sources indicates a substantial shift in the company's direction and significant investor interest.